1. Home
  2. ENTA vs FINW Comparison

ENTA vs FINW Comparison

Compare ENTA & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • FINW
  • Stock Information
  • Founded
  • ENTA 1995
  • FINW 1999
  • Country
  • ENTA United States
  • FINW United States
  • Employees
  • ENTA N/A
  • FINW N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • FINW Commercial Banks
  • Sector
  • ENTA Health Care
  • FINW Finance
  • Exchange
  • ENTA Nasdaq
  • FINW Nasdaq
  • Market Cap
  • ENTA 154.0M
  • FINW 182.3M
  • IPO Year
  • ENTA 2013
  • FINW 2021
  • Fundamental
  • Price
  • ENTA $5.10
  • FINW $14.73
  • Analyst Decision
  • ENTA Buy
  • FINW Buy
  • Analyst Count
  • ENTA 4
  • FINW 4
  • Target Price
  • ENTA $17.25
  • FINW $20.75
  • AVG Volume (30 Days)
  • ENTA 266.6K
  • FINW 22.7K
  • Earning Date
  • ENTA 05-05-2025
  • FINW 04-30-2025
  • Dividend Yield
  • ENTA N/A
  • FINW N/A
  • EPS Growth
  • ENTA N/A
  • FINW N/A
  • EPS
  • ENTA N/A
  • FINW 0.93
  • Revenue
  • ENTA $66,590,999.00
  • FINW $69,816,000.00
  • Revenue This Year
  • ENTA N/A
  • FINW $43.53
  • Revenue Next Year
  • ENTA N/A
  • FINW $21.91
  • P/E Ratio
  • ENTA N/A
  • FINW $15.84
  • Revenue Growth
  • ENTA N/A
  • FINW 8.45
  • 52 Week Low
  • ENTA $4.09
  • FINW $9.76
  • 52 Week High
  • ENTA $17.24
  • FINW $20.94
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 43.45
  • FINW 37.42
  • Support Level
  • ENTA $4.55
  • FINW $13.54
  • Resistance Level
  • ENTA $5.29
  • FINW $15.17
  • Average True Range (ATR)
  • ENTA 0.47
  • FINW 0.80
  • MACD
  • ENTA 0.06
  • FINW -0.04
  • Stochastic Oscillator
  • ENTA 63.96
  • FINW 28.03

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

Share on Social Networks: